Data Privacy

Employee turnover in the biopharma industry has reached unprecedented levels in recent years, causing a significant threat to intellectual property (IP) security. As the sector grapples with layoffs and recruitment shifts, there is an increasing need to understand how these workforce changes impact

Omnichannel marketing has been heralded as the next frontier in customer engagement, offering a seamless and integrated experience across various channels. The biopharmaceutical industry is no stranger to this trend, with a significant number of the top 100 pharmaceutical companies adopting

In the ever-evolving landscape of pharmaceuticals, the debate over regulatory data protection (RDP) is intensifying. As the Belgian Presidency of the Council of the EU approaches its twilight, policymakers are grappling with how to balance the imperatives of fostering pharmaceutical innovation with

The European Health Data Space (EHDS) marks a significant shift in healthcare within the European Union, profoundly affecting the management and usage of health data. It promises to empower EU citizens with better control over their health information while also improving clinical practices. The

The intersection of precision medicine and artificial intelligence (AI) is ushering in a transformative era, one where healthcare is redefined in its approach and interaction with patients. In a recent inspiring presentation, Dr. Eric Topol shared his insights into a not-so-distant future where AI

In a decisive move to safeguard financial stability and bolster public trust, the United States government has announced a significant intervention in the wake of the Silicon Valley Bank (SVB) failure. Unprecedented Access to Depositor Funds Starting on Monday, former clients of SVB are assured